Jane Street Group, LLC Allakos Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 52,495 shares of ALLK stock, worth $60,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,495

Previous 181,412 71.06%

Holding current value

$60,894

Previous $181,000 81.22%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.54 - $0.92 $69,615 - $118,603	-128,917 Reduced 71.06%	52,495 $34,000
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.45 $170,213 - $246,808	170,213 Added 1519.89%	181,412 $181,000
Q1 2024 May 15, 2024	SELL	$1.02 - $3.23 $144,024 - $456,076	-141,200 Reduced 92.65%	11,199 $14,000
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.18 $260,263 - $481,184	-151,316 Reduced 49.82%	152,399 $416,000
Q3 2023 Nov 14, 2023	BUY	$2.13 - $5.55 $460,955 - $1.2 Million	216,411 Added 247.88%	303,715 $689,000
Q2 2023 Aug 14, 2023	SELL	$3.6 - $5.25 $110,653 - $161,369	-30,737 Reduced 26.04%	87,304 $380,000
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $81,833 - $157,386	19,031 Added 19.22%	118,041 $525,000
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $355,776 - $529,264	62,858 Added 173.87%	99,010 $833,000
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $151,072 - $306,146	-50,024 Reduced 58.05%	36,152 $221,000
Q3 2022 Nov 14, 2022	SELL	$3.02 - $6.12 $151,072 - $306,146	-50,024 Reduced 58.05%	36,152 $221,000
Q2 2022 Aug 16, 2022	BUY	$2.6 - $6.14 $89,856 - $212,198	34,560 Added 66.96%	86,176 $269,000
Q1 2022 May 17, 2022	BUY	$5.08 - $9.81 $31,821 - $61,449	6,264 Added 13.81%	51,616 $294,000
Q4 2021 Feb 15, 2022	BUY	$8.55 - $111.89 $352,781 - $4.62 Million	41,261 Added 1008.58%	45,352 $444,000
Q3 2021 Nov 16, 2021	SELL	$76.53 - $110.43 $356,782 - $514,824	-4,662 Reduced 53.26%	4,091 $433,000
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $747,243 - $998,717	8,753 New	8,753 $747,000
Q1 2021 May 18, 2021	SELL	$109.73 - $153.66 $542,285 - $759,387	-4,942 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$79.58 - $152.45 $720,676 - $1.38 Million	-9,056 Reduced 64.69%	4,942 $692,000
Q3 2020 Nov 17, 2020	BUY	$66.43 - $90.99 $740,295 - $1.01 Million	11,144 Added 390.47%	13,998 $1.14 Million
Q2 2020 Aug 17, 2020	SELL	$44.04 - $80.69 $532,751 - $976,106	-12,097 Reduced 80.91%	2,854 $206,000
Q1 2020 May 15, 2020	BUY	$44.49 - $93.39 $551,320 - $1.16 Million	12,392 Added 484.25%	14,951 $665,000
Q4 2019 Feb 14, 2020	SELL	$66.49 - $137.73 $2,859 - $5,922	-43 Reduced 1.65%	2,559 $244,000
Q3 2019 Nov 14, 2019	SELL	$31.0 - $89.73 $253,766 - $734,529	-8,186 Reduced 75.88%	2,602 $205,000
Q2 2019 Aug 15, 2019	BUY	$36.0 - $44.73 $388,368 - $482,547	10,788 New	10,788 $467,000

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $98.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Allakos Inc. Transaction History